Weight Loss Medications
A discussion emerges around semaglutide and other GLP-1 related drugs, initially designed for diabetes but now gaining traction for obesity treatment. While these medications demonstrate impressive weight loss results, the conversation highlights the importance of lifestyle changes in achieving similar outcomes. The historical context of appetite-suppressing drugs reveals a pattern of both efficacy and concern regarding safety and addiction.In this clip
From this podcast
Huberman Lab
Dr. Chris Palmer: Diet & Nutrition for Mental Health | Huberman Lab Podcast #99
Related Questions
What does Andrew Huberman say about semaglutide, also known as GLP-1, in the episode How to Lose Fat with Science-Based Tools | Huberman Lab Podcast #21 and the clip GLP-1 Insights?
What are your opinions on GLP-1s like semaglutide as discussed in the episode How to Lose Fat with Science-Based Tools | Huberman Lab Podcast #21 and the clip GLP-1 Insights?
What are your opinions on GLP-1s like semaglutide as discussed in the Huberman Lab Podcast episode "How to Lose Fat with Science-Based Tools | Huberman Lab Podcast #21" and the clip "GLP-1 Insights"?